Plasma N-terminal pro-B-type natriuretic peptide concentration helps to predict survival in dogs with symptomatic degenerative mitral valve disease regardless of and in combination with the initial clinical status at admission
✍ Scribed by François Serres; Jean-Louis Pouchelon; Laure Poujol; Hervé P. Lefebvre; Cathy Trumel; Thomas Daste; Carolina Carlos Sampedrano; Vassiliki Gouni; Renaud Tissier; Gerhard Hawa; Valérie Chetboul
- Publisher
- Elsevier Science
- Year
- 2009
- Tongue
- English
- Weight
- 520 KB
- Volume
- 11
- Category
- Article
- ISSN
- 1760-2734
No coin nor oath required. For personal study only.
✦ Synopsis
Objectives: Although mitral valve disease (MVD) is the most common canine heart disease, readily available prognostic markers of the disease are still lacking. The aim of this study was to evaluate the comparative ability of N-terminal pro-B-type natriuretic peptide plasma concentration (NT-proBNP) and various echocardiographic variables to predict outcome in dogs with MVD. Animals, materials and methods: Seventy-four dogs with ISACHC classes 2 and 3 MVD (Groups A and B, respectively) were prospectively recruited. NT-proBNP and * Corresponding author. Unite ´de Cardiologie d'Alfort, Ecole Nationale Ve ´te ´rinaire d'Alfort, 7 avenue du Ge ´ne ´ral de Gaulle,